News & Reports

Have some news you want to share with the Oregon Bio community?  Fill out our submission form.

Corporate Activity Tax Town Hall Meetings: Your Thoughts Wanted

The Oregon Department of Revenue invites you to take part in a discussion of the administrative rules for the state’s new Corporate Activity Tax. Traveling across Oregon, rule writers will sit down in a series of meetings over the next three weeks to hear the concerns, questions, and suggestions of those affected by the rules.

The full meeting schedule includes stops in Corvallis, Beaverton, Medford, Grants Pass, Eugene, Bend, Redmond, Hermiston, Boardman, Portland, and Salem. For out of out-of-state business taxpayers […]

September 26, 2019 |

OREGON AND SOUTHWEST WASHINGTON’S LIFE SCIENCE INDUSTRY: POSITIONING FOR GROWTH

Oregon Bio 2019: Innovating and Scaling for our Region’s Growth is the annual conference aimed at investors, start-up entrepreneurs, executives, researchers, policymakers and bio-supply chain sector executives, happening Oct. 29 in Portland.  #OregonBio2019

CONTACT: Dianne Danowski Smith, (503) 201-7019, @OregonBio

(Portland, Ore.)  – In only three minutes, rising-star researchers from high schoolers to post- doctoral investigators will highlight their research to more than 150 bioscience professionals, industry experts, enthusiasts, and judges at Oregon Bio 2019: Innovating and Scaling for […]

Request for Proposals: Cross-Gorge Incumbent Worker Training Grant

Now Accepting Proposals

EC Works and SCWDC are seeking proposals from employers, who straddle our shared labor shed and are looking for resources to support training for their current workforce. Qualified employers will have employees who live on both sides of the Columbia River (Washington and Oregon) and whose physical business location is situated in any one of the counties within the cross Gorge labor shed of: Hood River, Wasco, Sherman, Gilliam, Skamania and Klickitat. EC Works and SCWDC will fund […]

September 5, 2019 |

Voice of Industry: Q&A with RevMedx’s President and CEO

Andrew Barofsky, J.D., MBA, launched and leads RevMedx, a growing biotech firm in North Wilsonville focused on trauma care and hemorrhage control solutions. RevMedx develops products called X-STATâ, Parabelt, XGauze, Airwrap, and others. “Saving lives is our mission” stands as their business motto.

Barofsky is the outgoing Board Chair of the Oregon Bioscience Incubator at the Oregon Translational Research and Development Institute; he has also served on the Board of Oregon Bio. We reached out to him to talk about RevMedx’s […]

August 30, 2019 |

Oregon Business Plan: Executive survey to drive economic policy

Dear Colleague,

You are invited to complete a  5-10 minute survey sponsored by the Oregon Business Plan.

What is the Oregon Business Plan

As you may know, the Oregon Business Plan (OBP) is both a partnership of Oregon’s major business organizations and a strategy to grow jobs, raise incomes and reduce poverty by supporting policies for economic growth and well-being.

Why your perspective is so important to hear

As part of an effort to update the Oregon Business Plan’s strategy to grow the economy, […]

Oregon Bio View from Academia: Jackie Wirz, Ph.D. Part 2

A few weeks ago, we introduced a new occasional focus section called the View From Academia. We will spotlight the many leading professionals who work in our research universities and in our R&D community.  Today, we’re finishing our talk with Jackie Wirz, Ph.D., Assistant Dean for Graduate Studies and Director of Career and Professional Development at OHSU, where her job is to help students thrive and find success as new professionals. Here’s Part 2 of our discussion.

Q: How does your […]

August 16, 2019 |

Portland medical device maker raises $2M

By   – Staff Reporter, Portland Business Journal
Aug 8, 2019, 4:45pm EDT 
PBJ Article Link

Portland-based Sonivate Medical Inc. has raised more than $2 million, according to a form filed this week with the U.S. Securities and Exchange Commission.

The company, which makes a finger-mounted ultrasound probe, indicated it has about $900,000 yet to raise.

The last time we reported on Sonivate, in 2017, the company had just […]

August 13, 2019 |

OP-ED: Bioscience is moving the economic needle in Oregon

© 2019 by Daily Journal of Commerce. All rights reserved.

OP-ED: Bioscience is moving the economic needle in Oregon

An economic impact report released earlier this year showed Oregon’s 800-plus bioscience establishments contributed $6.5 billion to the state’s economy in 2017.

A new kid on the block is carving out space in the Oregon economy’s pecking order. Bioscience is a diverse array of establishments spanning industry, education and health care entities. It can be sorted into agricultural feedstock and industrial bioscience, drugs […]

August 8, 2019 |

Thermo Fisher, Genome Canada Ink C$6M Collaboration on Cancer NGS Assays

Jul 31, 2019 – staff reporter: genomeweb story link

NEW YORK – Thermo Fisher Scientific announced yesterday a three-year, C$6 million (US$4.5 million) collaboration with Genome Canada and the Ontario Institute for Cancer Research (OICR) to develop targeted next-generation sequencing-based assays and analysis software.

Under the terms of the agreement, the partners will develop three assays, one for rapid diagnosis of pancreatic cancer, and two for targeted treatments — in prostate and breast cancer.

The assays will simultaneously assess DNA and […]

August 1, 2019 |

NemaMetrix raises $5 million USD funding and strengthens senior team

Eugene, Oregon, USA, 29 July 2019: 

NemaMetrix, an Oregon-based company that provides phenotyping and functional analysis using C. elegans nematodes, today announced it has closed a $5 million USD funding round to expand its Precisome platform: a tool for in vivo testing for early drug discovery, agribio, and precision medicine. The platform provides rapid phenotypic analysis and functional assessment of humanized model organisms. The funding, led by Oregon Venture Fund, will accelerate the Company’s capacity to help researchers shorten their project timelines for testing disease […]

Beam Therapeutics has promoted Chief Scientific Officer Giuseppe "Pino" Ciaramella to president. He will continue to serve as the Cambridge, MA, biotech's CSO, a role he has held for ne [...]

Acceleron Pharma Inc. (NASDAQ: XLRN) announced Thursday that John Quisel, the company's executive vice president and chief business officer, is leaving to become CEO of a venture-backed biotechno [...]

Pentagon spokesman Jonathan Hoffman said that eight of the affected service members returned to the United States from an American military hospital in Germany. [...]

Pfizer isn't giving up in biosims despite early challenges. This week, it unveiled launches to three Roche blockbusters, with two already on the market. The biosims target Roche's Avastin, H [...]

What a difference a day makes in biotech: Yesterday, antibiotics player Summit Therapeutics was riding high after an $8.8 million cash infusion from the U.S. Biomedical Advanced Research and Developme [...]

A report out this week by PwC thinks that biotech could be in for a good year for deals as it sees the momentum from 2019 growing, although don't expect many megadeals. [...]

Bladder cancer may have been the first FDA-approved indication for Tecentriq--as the first PD-1/L1 inhibitor to enter the area--but that doesn't mean the Roche drug can always win there. The Roch [...]

Patients with epithelioid sarcoma previously had no targeted treatment options, but that'll change with Epizyme's approval for Tazverik. The FDA signed off on the drug Thursday, and the comp [...]